Bacil Pharma Ltd
₹20.34▼ -1.07 (-5.00%)
BACPHAR·BSE·Healthcare
Market Cap
28.42 Cr
PE Ratio
18.32
Volume
259
Day High - Low
21.41 - 20.34
52W High-Low
61.80 - 10.65
₹20.34▼ -1.07 (-5.00%)
Market Cap28.42 Cr
PE Ratio18.32
Volume259
Day High - Low21.41 - 20.34
52W High-Low61.80 - 10.65
Bacil Pharma Ltd (BACPHAR): company summary
The company's business is not generating any revenue or profit, with annual revenue and net profit both at ₹0 crore.
Bacil Pharma Ltd (BACPHAR) is a micro-cap Healthcare company valued at ₹28 crore operating in Pharmaceuticals on the NSE and BSE.
- Recent price move
- Bacil Pharma Ltd last traded at ₹20.34, sharply down 5.00% on the day.
- Financial performance
- The company's business is not generating any revenue or profit, with annual revenue and net profit both at ₹0 crore. The latest quarter shows no change in net profit compared to the same quarter a year earlier, while annual net profit surged by 290.0% from a loss to a profit of ₹2 crore.
- Valuation multiples
- The stock trades at 18.3 times earnings, a discount to the Healthcare median of 32.0, 1.05 times book value.
- Things to watch
- The company has no core operating revenue or profit, and its latest quarter net profit remained at ₹0 crore despite a 800.0% change in the quarter versus the same quarter a year earlier. The stock is 65.4% below its 52-week high, indicating a significant drop in value.
- Where it stands
- The company remains non-operating with no revenue or profit in the latest quarter, and its stock is far below its recent peak. The most significant figure is the 65.4% drop from the 52-week high.
Summarised by DocStoX's model on 2026-10-18 from company filings, exchange data and news. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.
DocStoX Score
1.6/10
Poor
Fair Value
Sign in to see
ROE
6.27%
Weak
P/E
18.32x
Fair
Debt / Equity
0.00
Low
Industry
Healthcare
Pharmaceuticals
Overall View
Poor
Price performance
Day₹20.34
₹21.41
52W₹10.65
₹61.80
DocStoX take
Held back by quality (0.1). Scored on 4 of 5 measures.
DocStoX score
Low confidence1.6
/10
Poor
Quality
Weak
ROE 6.3%
Valuation
Fair
P/E 18.3×
Growth
No data
No multi-year history
Risk
Moderate
D/E 0.00
Momentum
Weak
19% of 52-week range
Scored on 4 of 5 measures — the rest have no data for this company.
At a glance
Market Cap
₹28 Cr
52W High / Low
₹62 / ₹11
Dividend Yield
0.00%
Promoter Holding
0.00%
EPS (TTM)
₹1.11
Book Value
₹17.76
Key highlights
- Low leverage — D/E 0.00
- Loss-making in some of the last 5 years
- Quality is weak (0.1/10)
1 Positive4 Watchouts
Growth
Financials
Technicals
Peers
News
Forecasts
About the company
More data
Filings, corporate actions and ownership detail — opened on demand.
More Healthcare stocks · Pharmaceuticals
Explore Bacil Pharma Ltd’s valuation
Free deep-dive tools · no sign-up
Fair ValueOur fair-value estimate, upside, and Bear/Base/Bull scenarios.Intrinsic ValueGraham & earnings-power intrinsic value with margin of safety.DCFDiscounted cash flow — free cash flow, growth, value per share.ValuationP/E, P/B, earnings yield and the full multiples picture.Financial RatiosProfitability, leverage and efficiency ratios at a glance.PeersHow it stacks up against its closest listed competitors.
Bacil Pharma Ltd peers in Healthcare
Other Healthcare stocks on the NSE & BSE. See the full Healthcare sector list.
Related tools & concepts
Value Bacil Pharma Ltd with the ratios and calculators DocStoX uses in its analysis.
P/E RatioPrice to earningsReturn on Equity (ROE)ProfitabilityROCECapital efficiencyDebt to EquityLeverageP/B RatioPrice to bookNet Profit MarginBottom-line efficiencyDCF / Intrinsic ValueEstimate fair valueCAGR CalculatorAnnualised returnDividend YieldIncome on pricePosition SizeRisk-based sizingBrokerage CalculatorCharges on a tradeSIP CalculatorSystematic investing